Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
23.90
-0.09 (-0.38%)
At close: Apr 24, 2026, 4:00 PM EDT
24.00
+0.10 (0.42%)
After-hours: Apr 24, 2026, 4:17 PM EDT
Legend Biotech Employees
Legend Biotech had 2,965 employees as of December 31, 2025. The number of employees increased by 356 or 13.65% compared to the previous year.
Employees
2,965
Change (1Y)
356
Growth (1Y)
13.65%
Revenue / Employee
$347,015
Profits / Employee
-$100,101
Market Cap
4.42B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2,965 | 356 | 13.65% |
| Dec 31, 2024 | 2,609 | 783 | 42.88% |
| Dec 31, 2023 | 1,826 | 436 | 31.37% |
| Dec 31, 2022 | 1,390 | 319 | 29.79% |
| Dec 31, 2021 | 1,071 | 189 | 21.43% |
| Dec 31, 2020 | 882 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| ACADIA Pharmaceuticals | 798 |
| Apellis Pharmaceuticals | 739 |
| Corcept Therapeutics | 730 |
| Crinetics Pharmaceuticals | 594 |
| Amicus Therapeutics | 511 |
| Travere Therapeutics | 497 |
| Xenon Pharmaceuticals | 370 |
| Tango Therapeutics | 137 |
LEGN News
- 6 weeks ago - Legend Biotech Reports Fourth Quarter and Full Year 2025 Results and Recent Highlights - GlobeNewsWire
- 2 months ago - Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2025 Results - GlobeNewsWire
- 4 months ago - Top 3 Health Care Stocks You'll Regret Missing This Quarter - Benzinga
- 4 months ago - Cancer Study Buoys These Small Biotechs - Barrons
- 4 months ago - Legend Biotech Highlights New CARVYKTI® Data in Multiple Myeloma and First-in-Human Results from Novel CAR-T Platform in Non-Hodgkin Lymphoma at ASH 2025 - GlobeNewsWire
- 5 months ago - Legend Biotech Celebrates Official Opening of New State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia - GlobeNewsWire
- 6 months ago - Legend Biotech Announces 10 Presentations at the 67th American Society of Hematology (ASH) Annual Meeting - GlobeNewsWire
- 6 months ago - Legend Biotech to Host Investor Conference Call on Third Quarter 2025 Results - GlobeNewsWire